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Summary  Surgical  site  infection  (SSI)  is  a  major  surgical  complication  that  leads
to  mortality,  morbidity  and  socioeconomic  losses.  The  objective  of  this  study  is
to  determine  the  rate  of  SSIs,  the  pathogens  involved  in  the  infections  and  the
associated  antimicrobial  sensitivity  patterns  in  the  surgical  clinics  of  our  hospital.
This  study  was  conducted  in  all  surgical  departments  of  our  hospital  except  oph-
thalmology.  Patients  (n  =  1397)  who  had  surgery  for  any  reason  and  who  stayed  in
the  hospital  for  at  least  48  h  were  enrolled  in  this  study.  The  criteria  issued  by  the
Centers  for  Disease  Control  and  Prevention  was  utilized  in  deﬁning  and  diagnosing
SSI.
During  the  study,  SSIs  developed  in  131  (9.4%)  of  1397  patients.  The  develop-
ment  of  a  SSI  resulted  in  an  additional  12.8  days  of  hospital  stay.  Gram-negative
microorganisms  constituted  74.6%  of  the  pathogens  responsible  for  the  SSIs.  The
most  commonly  isolated  microorganisms  were  Escherichia  coli  (32.8%),  Pseudomonas
spp.  (13.4%)  and  Enterococcus  spp.  (11.9%).  Methicillin  resistance  in  Staphylococ-
cus  aureus  and  coagulase-negative  staphylococci  was  83.3%  and  100%,  respectively.
No  vancomycin  resistance  was  detected  in  the  enterococci.  The  rates  of  extended
spectrum  beta  lactamase  production  in  E.  coli  and  Klebsiella  strains  were  86.3%  and
42.8%,  respectively.
SSI  surveillance  studies  should  be  performed  to  decrease  the  rate  of  SSIs.
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Introduction
Observations  over  the  past  30  years  have  revealed
that surgical  site  infections  (SSIs)  are  responsible
for 1/4  of  all  hospital  infections  [1].  SSIs  are  the
most signiﬁcant  and  preventable  cause  of  morbidity
and mortality  in  surgical  patients  [2].  The  dura-
tion of  the  hospital  stay  is  extended,  and  treatment
costs are  increased  in  patients  with  SSIs,  leading  to
substantial  economic  losses  [3].
In the  current  study,  the  objective  was  to  deter-
mine the  rate  of  SSIs,  the  pathogens  involved,  the
antibiotic  sensitivity  patterns  and  the  types  and
administration  methods  of  prophylactic  antibiotics
used  in  surgical  procedures  at  Gaziantep  University
Medical Faculty  Hospital.  The  National  Nosocomial
Infections Surveillance  (NNIS)  diagnostic  criteria
recommended by  the  Centers  for  Disease  Control
(CDC) were  used  to  standardize  the  study  and  to
compare  the  data  with  previous  publications.
Materials and methods
Preliminary  data  from  the  surveillance  of  surgi-
cal site  infections,  conducted  for  the  ﬁrst  time  at
Gaziantep  University  Medical  Faculty,  were  evalu-
ated in  this  study.  The  study  covered  the  initial  16
weeks of  the  surveillance  and  took  place  between
17.03.2008 and  10.07.2008.
This  study  was  conducted  in  all  surgical  depart-
ments of  Gaziantep  University  Medical  Faculty
except the  ophthalmology  department.  Patients
(n =  1397)  who  had  surgery  for  any  reason  and  who
stayed  in  the  hospital  for  at  least  48  h  were  enrolled
in the  study.  Patients  who  underwent  operation
in the  Daily  Hospital,  had  a  caesarean  section  or
were discharged  from  the  hospital  within  2  days  of
surgery were  excluded  from  the  study.
A physician  and  a  nurse  from  the  hospital  infec-
tion control  committee  implemented  an  active,
prospective and  patient-based  study  design  and
performed  the  surveillance  study.  The  surgical
departments were  visited  daily,  and  a  patient  mon-
itoring form  was  completed  for  each  patient.  All
subjects  received  a  follow-up  during  their  stay  in
the hospital;  no  further  follow-up  was  conducted
after discharge  from  the  hospital.
The deﬁnitions  issued  by  the  CDC  were  used
to describe  SSIs  [4]. The  characteristics  of  the  SSI
patient group,  including  age,  gender  and  length  of
hospital stay,  were  compared  with  a  control  group
of patients  who  exhibited  no  development  of  SSIs.
To determine  the  microorganisms  causing  the
SSIs, samples  were  obtained  from  incision  sites  and
l
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rgans/cavities  suspected  of  being  infected.  Swab
amples  obtained  on  sterile  swabs  were  placed
n carrier  media,  while  samples  obtained  from
rgans/cavities (cerebrospinal  ﬂuid,  pleural  ﬂuid)
ere placed  in  sterile  tubes  and  transferred  to
he microbiology  laboratory  of  our  hospital.  The
amples  were  incubated  in  5%  blood  agar  and
osin-methylene blue  agar  for  24—48  h.  To  grow
naerobic  microorganisms,  the  samples  were  incu-
ated in  Schaedler  agar  in  an  anaerobic  jar  for
8—72 h.  Identiﬁcation  of  microorganisms  growing
n the  agar  plates  was  performed  by  conventional
ethods (gram  staining,  motility  assessment,  cata-
ase testing,  oxidase  testing)  and  by  the  Vitek  2
ompact (BioMerieux,  France)  system.  Antibiotic
ensitivities were  assessed  by  the  disc  diffusion
ethod according  to  the  criteria  of  the  Clini-
al and  Laboratory  Standards  Institute  (CLSI)  [5].
pecies exhibiting  a medium  level  of  sensitivity
ere included  in  the  resistant  group.
The  acceptability  of  prophylactic  antibiotic
election and  the  duration  of  prophylaxis  were  eval-
ated by  recommendations  indicated  in  the  ‘‘Guide
or Prevention  of  Surgical  Site  Infections’’  issued  by
he CDC  in  1999.
This  trial  was  approved  by  the  Gaziantep  Univer-
ity Medical  Faculty  Medical  Ethical  Committee  on
8.06.2009  (approval  no.  06-2009/253).
esults
 total  of  1397  patients  in  19  surgical  depart-
ents at  Gaziantep  University  Medical  Faculty  were
nrolled in  the  study.  The  distribution  of  patients  in
arious departments  and  the  rates  of  SSIs  are  shown
n Table  1. Among  the  subjects,  706  were  male
50.5%) and  691  were  female  (49.5%).  The  mean
ge of  the  patients  was  41.4  ±  22.4  years.  The  mean
ge of  patients  with  SSIs  was  48.1  ±  20.7  years,
hile the  mean  age  of  patients  without  SSIs  was
0.6 ±  22.4  years  (p  <  0.001).  While  the  postopera-
ive stay  in  the  hospital  was  17.9  ± 11.7  days  in  the
SI group,  the  duration  of  stay  was  5.1  ±  4.0  days  in
he non-SSI  group.  Development  of  a SSI  caused  a
2.8-day  increase  in  the  length  of  the  hospital  stay.
n a statistical  analysis  performed  using  indepen-
ent samples  T-test,  the  development  of  infection
as found  to  signiﬁcantly  increase  the  duration  of
he hospital  stay  (p  <  0.001).  The  SSIs  developed
fter a  mean  duration  of  8.5  ±  5.2  (2—36)  days  fol-
owing  surgery.
SSIs developed  in  131  of  the  1397  patients
nrolled in  the  study,  with  a net  SSI  rate  of  9.4%.
he distribution  of  SSIs  revealed  67  superﬁcial
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Table  1  Distribution  of  patients  and  rates  of  SSIs  in  various  departments.
Department  Number  of  patients  Number  of  patients  with  SSIs  Rate  of  SSIs
(n)  %  (n)  %
General  surgery  328  23.5  39  11.9
Orthopedics  275  19.7 17  6.2
Cardiovascular  surgery 136  9.7 16  11.8
Gynecology  &  obstetrics  133  9.5  7  5.3
Neurosurgery  110  7.9  10  9.1
Ear,  nose  and  throat  surgery  98  7.0  9  9.2
Urology  95  6.8  10  10.5
Thoracic  surgery  87  6.2  10  11.5
Plastic  and  reconstructive  Surgery  82  5.9  8  9.8
Pediatric  surgery  53  3.8  5  9.4
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ncisional  (51.1%),  43  deep  incisional  (32.8%)  and
1 organ/cavity  SSIs  (16%).  SSIs  developed  at
he highest  rates  after  prostatectomy  (33.3%),
olon surgery  (27.1%)  and  bile  duct,  liver  and
ancreas surgery  (25%).  Procedure-speciﬁc  SSI
ates are  shown  in  Table  2. Evaluation  of  SSI  rates
ccording  to  various  departments  revealed  that  the
ighest rates  were  in  the  Department  of  General
urgery (11.9%),  the  Department  of  Cardiovascular
urgery (11.8%)  and  the  Department  of  Thoracic
urgery (11.5%).  However,  analysis  by  the  Pearson
hi-square  test  did  not  reveal  any  statistically
h
w
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Table  2  Procedure-speciﬁc  SSI  rates.
NNIS  Operation  Category  Rate  of  SSI  N
n/N %  C
Amputation  4/20  20.0  N
Appendectomy  1/18  5.6  P
Bile  duct,  liver,  pancreas  6/24  25.0  S
Cardiac  surgery  5/63  7.9  S
CABG  (thoracic  and  leg)  8/44  18.2  S
CABG  (only  thoracic)  0/3  0  T
Cholecystectomy  2/42  4.8  V
Colon  surgery  13/48  27.1  V
Craniotomy  6/63  9.5  V
Spinal  fusion  3/15  20.0  E
Reduction  of  open  fracture  8/73  10.9  O
Gastric  surgery  2/20  10.0  O
Hernia  repair  3/26  11.5  E
Head  and  neck  surgery  6/44  13.6  O
Hip  prosthesis  1/13  7.7  O
Abdominal  hysterectomy  4/45  8.9  O
Knee  prosthesis  1/23  4.3  O
Laminectomy  0/16  0  O
Mastectomy  1/24  4.2  O
CABG: coronary artery bypass surgery, NNIS: National Nosocomial I
trointestinal system, GUS: genitourinary system, ENT: ear, nose and131  100.0
igniﬁcant  differences  among  the  SSI  rates  in
arious departments  (p  =  0.35).
Antimicrobial  prophylaxis  was  given  to  1210
atients (86.6%),  while  21  patients  received  no
ntimicrobial  treatment  (1.5%).  A  total  of  166
atients  (11.9%)  were  treated  with  antibiotics
or therapeutic  purposes  due  to  contaminated  or
irty-infected  wounds,  rather  than  prophylaxis.
o prophylaxis  was  given  to  21  patients  who
ad clean  and  clean-contaminated  wounds  (1.7%),
hile prophylaxis  was  initiated  in  1210  patients
98.3%) (Table  3).  One  dose  of  an  antibiotic  was
NIS  operation  Rate  of  SSI
ategory  n/N  %
ephrectomy  2/32  6.3
rostatectomy  2/6  33.3
mall  intestinal  surgery  0/9  0
kin  grafts  3/31  9.7
plenectomy  0/23  0
horacic  surgery  9/59  15.3
aginal  hysterectomy  1/14  7.1
ascular  surgery  3/21  14.3
entricular  shunt  surgery  0/6  0
xplorative  laparotomy  15/91  16.5
ther  cardiovascular  surgery  0/6  0
ther  ENT  surgery  3/61  4.9
ndocrine  surgery  2/46  4.3
ther  GIS  surgery  1/17  5.9
ther  GUS  surgery  7/129  5.4
ther  musculoskeletal  surgery  7/159  4.4
ther  neurosurgery  0/10  0
ther  respiratory  surgery  1/25  4.0
ther  skin  &  append.  surgery  1/28  3.6
nfections Surveillance, SSI: surgical site infections, GIS: gas-
 throat.
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Table  3  Use  of  antibiotics  in  prophylaxis.
Patients  with  clean  and
clean-contaminated  wounds  (n)
Patients  with  dirty  and
contaminated  wounds  (n)
Total
N  =  1231  %  N  =  166  %  N  =  1397  %
Prophylaxis  (−)  21  1.7  —  —  21  1.5
Prophylaxis  (+)  1210  98.3  —  —  1210  86.6
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was found  in  9%  of the  E.  coli  strains,  14%  of  the
Klebsiella  strains,  22%  of  the  Pseudomonas  strains
and 50%  of  the  Acinetobacter  strains.  Antibiotic
Table  5  Antibiotics  used  in  antimicrobial
prophylaxis.
Antibiotic n %Treatment  —  —  
administered  during  the  induction  of  anesthesia
in 10  of  1210  patients  (0.8%);  60  patients  (4.9%)
used a  prophylactic  antibiotic  for  less  than  one
day, while  antibiotic  prophylaxis  was  carried  out  for
more than  one  day  in  1140  patients  (94.2%).  One
antibiotic  was  used  for  antimicrobial  prophylaxis  in
1022 patients  (84.5%),  with  two  antibiotics  used  in
156 patients  (12.9%)  and  three  antibiotics  used  in
32 patients  (2.6%)  (Table  4).  The  selected  antibi-
otic was  regarded  as  inappropriate  in  333  patients
(27.5%)  that  received  antimicrobial  prophylaxis,
while the  duration  of  prophylaxis  was  determined
to be  inappropriate  in  1140  patients  (94.2%).  The
agents most  commonly  used  for  antimicrobial  pro-
phylaxis  were  cefazolin  (53.1%),  cefuroxime  axetil
(17.8%),  third-generation  cephalosporins  (8.5%)  and
aminopenicillin  (4.5%).  The  antibiotics  used  for
antimicrobial  prophylaxis  are  shown  in  Table  5.
For 55  of  the  patients  with  SSIs  (42%),  67
microorganisms grew  in  culture  samples  of  incision
sites.  Among  the  patients  with  evidence  of  bac-
terial growth  in  culture,  43  (78%)  specimens  were
monomicrobial,  and  in  12  (21.8%)  of  the  cultures,
2 pathogens  were  isolated.  The  most  frequently
isolated microorganisms  were  Escherichia  coli
(32.8%),  Pseudomonas  spp.  (13.4%)  and  Enterococ-
cus spp.  (11.9%)  (Table  6).  Among  the  pathogens
Table  4  Duration  of  prophylaxis  and  number  of
antibiotics  used  in  prophylaxis.
Number  of
patients  (n)
N =  1210
%
Duration  of
prophylaxis
Single  dose
during
induction  of
anesthesia
10 0.8
<1  day  60  4.9
>1  day  1140  94.2
One  1022  84.5
Two  156  12.9
Three  32  2.6166  100  166  11.9
dentiﬁed,  74.6%  were  Gram-negative,  and  25.4%
ere Gram-positive.  No  anaerobic  bacteria  or  fungi
ere grown.
An assessment  of  antibiotic  resistance  among
gent pathogenic  microorganisms  revealed  methi-
illin resistance  in  7  of  8 staphylococci  strains
87.5%). Methicillin  resistance  was  found  in  83.3%
5/6) of  Staphylococcus  aureus  strains  and  in
00% (2/2)  of  coagulase-negative  staphylococci.  All
taphylococci  strains  were  sensitive  to  vancomycin.
o vancomycin  resistance  was  found  in  the  entero-
occi. The  production  of  extended  spectrum  beta
actamase  (ESBL)  was  detected  in  86.3%  and  42.8%
f the  E.  coli  and  Klebsiella  strains,  respectively,
ielding a  total  rate  of  75.8%.  Imipenem  resistanceused
Cefazolin  642  53.1
Cefuroxime
axetil
215  17.8
Third-
generation
cephalosporins
103  8.5
Aminopenicillin  54  4.5
Third-
generation
cephalosporins  +  5-
nitroimidazole
group
34  2.8
Cefazolin  +  aminoglycoside  +  5-
nitroimidazole
group
22  1.8
Cefazolin  +  aminoglycoside  17  1.4
Third-
generation
cephalosporins  +  aminoglycoside
14  1.2
Other  43  3.4
Total  1210  100
Preliminary  data  of  the  surveillance  of  surgical  site  
Table  6  Isolated  microorganisms.
Microorganism  N
n  =  67  %
E.  coli 22 32.8
Pseudomonas  spp. 9  13.4
Enterococcus  spp.  8  11.9
Klebsiella  spp.  7  10.4
S.  aureus  6  9.0
Acinetobacter  spp.  6  9.0
Enterobacter  spp.  3  4.5
Coagulase-negative  staphylococci  2  3.0
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Burkholderia  cepacia  1  1.5
esistance  rates  in  the  Gram-negative  bacteria  are
hown in  Table  7.
iscussion
he  rate  of  SSIs  in  the  current  study  was  deter-
ined to  be  9.4%.  Because  no  surveillance  study
as conducted  after  hospital  discharge,  the  actual
ate of  SSIs  may  be  higher  than  the  calculated  rate.
n similar  studies  conducted  in  our  country,  Kaya
t al.  found  a  similar  rate  of  SSI  (8.8%)  [6],  Topalog˘lu
t al.  [7]  found  a  higher  rate  of  14.1%  and  Cos¸kun
t al.  found  a  lower  rate  of  7.6%  [8].  In  multicen-
er national  surveillance  studies  in  Spain,  France
nd the  USA,  the  rates  of  SSI  were  calculated  as
.3%, 3.4%  and  2.6%,  respectively  [9—11].  The  lower
ates determined  in  these  countries  may  be  because
here  is  efﬁcient  surgical  site  surveillance  in  these
ountries,  which  is  followed  by  the  implementation
f SSI  control  measures  based  on  these  surveillance
ata, while  this  study  was  the  ﬁrst  surveillance
tudy in  our  hospital.
In  the  ‘‘Guide  for  Prevention  of  Surgical  Site
nfections’’ issued  by  the  CDC  in  1999,  SSIs  are
s
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Table  7  Antibiotic  resistance  rates  in  Gram-negative  bact
Antibiotics  E.  coli
(n =  22)
Klebsiella
spp.  (n  =  7)
Amikacin  55  29  
Ampicillin/sulbactam  91  60  
Gentamycin  64  50  
Imipenem  9  14  
Ceftazidime  86  43  
Ceftriaxone
Ciproﬂoxacin
Cefoperazone/sulbactam
TMP/SMX
Abbreviations: TMP/SMX: trimethoprim/sulfamethoxazole.293
lassiﬁed  as  incisional  (superﬁcial  or  deep)  and
rgan/cavity  infections;  2/3  of  SSIs  are  incisional,
hile organ/cavity  SSIs  constitute  the  remaining
/3 [4]. In the  current  study  of  SSIs,  51.1%  were
esignated as  superﬁcial  incisional,  32.8%  as  deep
ncisional  and  16%  as  organ/cavity  SSIs.
The prevalence  of  SSI  varies  according  to  the
ype of  surgery  performed.  The  procedure-speciﬁc
ate of  SSIs  in  our  study  revealed  the  highest  rates
f 33.3%  in  prostatectomy,  27.1%  in  colon  surgery
nd 25%  in  bile  duct,  liver  and  pancreas  surgery.  The
umber of  data  points  for  each  NNIS  operation  cate-
ory is  not  sufﬁcient  to  execute  a proper  statistical
valuation. The  number  of  patients  that  underwent
rostatectomy is  only  six,  and  SSIs  developed  in
wo of  these  cases.  The  highest  rate  of  SSI  may  be
egarded  as  the  rate  found  in  colon  surgery  (27.1%).
n a  trial  performed  in  Ondokuz  Mayıs  University  by
ıs¸gın et  al.  [12], the  rate  of  SSIs  among  patients
ndergoing colon  surgery  was  determined  to  be
7%. In  a study  conducted  in  Russia,  colon  surgery
resented the  highest  rate  (27%)  of  SSIs  [13].
In the  current  study,  development  of  a  SSI  caused
 12.8-day  increase  in  the  duration  of  hospital  stay.
n studies  conducted  in  the  USA  during  1950—1980,
ospital stays  were  reported  to  be  7—24  days  longer
n different  publications  [14,15]. In  the  1980s,  strict
nfection control  measures  led  to  a 50%  decrease
n additional  days  in  the  hospital6. In  a study  per-
ormed  by  Kirkland  et  al.  [16],  hospital  stays  were
ncreased  by  6.5  days,  while  Lissovoy  et  al.  [3]
eported  an  increase  of  9.7  days.
In the  multicenter  study  conducted  by  Hos¸og˘lu
t al.  [17]  entitled  ‘‘National  Study  of  Surgi-
al Antibiotic  Prophylaxis  in  Turkey’’,  the  authors
eported  the  following  data  on  clean-contaminated
urgical  cases:  no  prophylaxis  (6%),  inappropri-
te choice  of  antibiotics  (32%),  single-dose  use  of
n antibiotic  (12%)  and  prophylaxis  for  a dura-
ion longer  than  24  h  (80%).  The  most  commonly
eria  speciﬁed  as  the  infectious  agent  in  SSIs  (%).
Enterobacter
spp. (n  =  3)
Pseudomonas
spp.  (n  =  9)
Acinetobacter
spp. (n  =  6)
100  33  57
100  —  33
67  44  57
0  22  50
67  55  100
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used  agents  in  prophylaxis  were  third-generation
cephalosporins  (42%)  and  cefazolin  (30%).  In  the
current study,  there  was  no  prophylactic  use
of antibiotics  in  1.7%  of  the  clean  and  clean-
contaminated  surgical  operations,  and  the  use
of inappropriate  antibiotics  occurred  in  27.5%  of
cases. The  rate  of  single-dose  antibiotic  use  dur-
ing induction  of  anesthesia  was  only  0.8%.  In
the same  group,  the  percentage  of  patients  who
received antibiotic  prophylaxis  for  less  than  24  h
was 4.9%,  and  more  than  24  h  of  prophylaxis  was
given to  94.2%  of  the  patients.  The  most  frequently
used agents  for  prophylaxis  were  cefazolin  (53.1%),
cefuroxime axetil  (17.8%)  and  third-generation
cephalosporins  (8.5%).
In  a  study  conducted  in  a  university  hospital  in
Greece  by  Roumbelaki  et  al.  [18], bacterial  growth
was observed  in  culture  for  70.5%  of  SSIs,  and  37.4%
of these  cases  were  determined  to  be  polymicro-
bial. In  our  study,  growth  in  culture  was  observed
in 42%  of  the  SSI  cases,  and  21.8%  of  these  cases
were determined  to  be  polymicrobial.  The  low  rate
of growth  in  culture  observed  in  the  current  study
may be  due  to  the  surgeons  in  our  hospital  dis-
regarding the  necessity  of  obtaining  cultures  or
of attaining  timely  and  appropriate  culture  sam-
ples. In the  study  by  Roumbelaki  et  al.  [18], 52.1%
of isolated  microorganisms  were  Gram-positive,
38.2% were  Gram-negative,  5.5%  were  anaerobic
bacteria and  4.2%  were  candida  strains.  The  most
commonly  encountered  pathogenic  agents  were
enterococci  strains  (22.4%),  S.  epidermidis  (15.1%),
E. coli  (9.7%)  and  P.  aeruginosa  (9.7%).  In  a  study
performed  in  Sudan,  S.  aureus  was  reported  as
the pathogen  in  55%  of  cases  [19].  According  to
NNIS data  in  the  USA  for  1986  and  1996,  Gram-
positive bacteria  (S.  aureus,  coagulase  negative
staphylococci and  enterococci)  were  the  most  com-
mon agents  associated  with  SSIs  [20].  In  our  trial,
74.6%  of  the  pathogens  were  Gram-negative  and
25.4% were  Gram-positive  bacteria,  and  no  anaer-
obic bacteria  or  fungi  were  isolated.  The  most
common pathogens  isolated  in  the  current  study
were E.  coli  (32.8%),  Pseudomonas  spp.  (13.4%)  and
Enterococcus  spp.  (11.9%).  The  relatively  more  fre-
quent isolation  of  Gram-negative  bacteria  as  the
infectious  agent  in  SSIs  in  the  current  study  may
be due  to  the  intervention  of  gastrointestinal  and
genitourinary  systems  in  most  of  the  SSI  cases  due
to the  ﬂora  of  these  systems.  Higher  isolation  rates
of resistant  nosocomial  Gram-negative  pathogens
suggest insufﬁcient  postoperative  wound  care  and
infection control  measures.
The  antibiotic  sensitivities  of  microorganisms
isolated  as  the  infectious  agents  in  SSI  in  the  cur-
rent study  revealed  higher  methicillin  resistance  in
t
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taphylococcus  strains,  higher  ESBL  rates  in  E.  coli
nd Klebsiella  spp.  and  higher  antibiotic  resistance
ates in  Pseudomonas  spp.  and  Acinetobacter  spp.,
ompared  to  the  resistance  rates  determined  in  two
tudies in  Turkey  [12,21].
In a  2006  study  conducted  in  our  country  by
etin et  al.  [21]  to  assess  the  proﬁle  of  microor-
anisms and  the  antibiotic  sensitivities  in  SSIs,  36%
f isolated  S.  aureus  strains  and  52%  of  coagulase-
egative staphylococci  were  found  to  be  resistant
o methicillin,  while  no  vancomycin  resistance
as observed  in  enterococci  strains.  In  the  cur-
ent study,  the  methicillin-resistant  S.  aureus  and
oagulase-negative  staphylococci  strain  rates  were
3.3% and  100%,  respectively,  while  no  vancomycin
esistance was  observed  in  enterococci  strains.  In
he study  conducted  by  C¸etin  et  al.  [21], imipenem
esistance in  Gram-negative  bacteria  was  2%  in  E.
oli, 7%  in  Klebsiella  spp.,  38%  in  Acinetobacter
pp. and  5%  in  Pseudomonas  spp.  The  correspond-
ng rates  in  the  current  study  were  9%,  14%,  30%  and
0%, respectively.  In the  trial  performed  by Fıs¸gın
t al.  [12]  on  patients  undergoing  colon  surgery,  the
SBL rate  was  50%  in  E.  coli  and  Klebsiella  strains
solated as  the  agent  pathogens  for  SSIs,  while  the
orresponding  rate  in  our  study  was  75.8%.
In the  study  conducted  by  C¸etin  et  al.  [21],
esistance against  antibiotics  in  Pseudomonas  spp.
as 5%  for  amikacin,  5%  for  gentamycin,  5%  for
mipenem, 14%  for  piperacillin,  5%  for  ceftazidime,
4% for  ciproﬂoxacin  and  14%  for  cefoperazone.
he corresponding  rates  of  resistance  in  our  trial
ere 33%  for  amikacin,  44%  for  gentamycin,  22%
or imipenem,  44%  for  piperacillin/tazobactam,
5%  for  ceftazidime,  55%  for  cefepime,  44%  for
iproﬂoxacin and  22%  for  cefoperazone/sulbactam.
he  most  sensitive  antibiotics  for  Pseudomonas  spp.
n the  current  study  were  imipenem  and  cefopera-
one/sulbactam.
The antibiotic  resistance  rates  of  Acinetobac-
er spp.  in  the  study  by  C¸etin  et  al.  [21]  were
6% for  amikacin,  24%  for  gentamycin,  38%  for
mipenem, 90%  for  piperacillin,  76%  for  ceftazidime
nd 71%  for  ciproﬂoxacin.  The  corresponding  rates
n the  current  study  were  57%  for  amikacin,
7% for  gentamycin,  50%  for  imipenem,  83%  for
iperacillin/tazobactam,  100%  for  ceftazidime,
3% for  cefepime,  67%  for  ciproﬂoxacin,  17%
or cefoperazone/sulbactam  and  33%  for  ampi-
illin/sulbactam. In  our  study,  the  most  sensitive
ntibiotics for  Acinetobacter  spp.  were  cefoper-
zone/sulbactam  and  ampicillin/sulbactam,  and
he high  sensitivity  rates  for  these  antibiotics  are
uggested  to  be  due  to  sulbactam.  In  a review  pub-
ished in  2002,  sulbactam  was  shown  to  have  direct
ntimicrobial  activity  against  Acinetobacter  spp.,
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[reliminary  data  of  the  surveillance  of  surgical  site
nd  the  use  of  sulbactam  as  monotherapy  or  in  com-
ination  with  ampicillin  or  cefoperazone  has  been
eported  to  provide  clinical  eradication  in  multiple-
rug-resistant  Acinetobacter  spp.  infections  [22].
Local SSI  surveillance  studies  are  recommended
o determine  the  rate  of  SSIs,  the  distribution  of
athogenic  microorganisms  in  SSIs  and  the  antibi-
tic sensitivities  of  microorganisms  in  each  center.
rophylaxis  and  empirical  treatment  of  SSIs  should
e based  on  local  surveillance  data.
eferences
[1] Nichols RL. Surgical wound infection. In: Bennett JV, Brach-
man PS, editors. Hospital infections. 4th ed. Philadelphia:
Lippincott-Raven; 1998. p. 909—15.
[2] Nichols RL. Prevention surgical site infections: a surgeon’s
perspective. Emerging Infectious Diseases 2001;7:220—4.
[3] de Lissovoy G, Fraeman K, Hutchins V, Murphy D, Song D,
Vaughn BB. Surgical site infection: Incidence and impact on
hospital utilization and treatment costs. American Journal
of Infection Control 2009;37:387—97.
[4] Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis
WR. Guideline for prevention of surgical site infec-
tion, 1999. Infection Control and Hospital Epidemiology
1999;20:247—78.
[5] The Clinical and Laboratory Standards Institute: perfor-
mance standards for antimicrobial disk susceptibility tests,
approved standards. 9th ed. (M2-A9) Wayne, PA: CLSI; 2008.
[6] Kaya E, Yetim I, Dervis¸og˘lu A, Sünbül M, Bek Y. Risk factors
for and effect of a one-year surveillance program on surgi-
cal site infection at a university hospital in Turkey. Surgical
Infections 2006;7:519—26.
[7] Topalog˘lu S, Akin M, Avsar FM, Ozel H, Polat E, Akin T, et al.
Correlation of risk and postoperative assessment meth-
ods in wound surveillance. Journal of Surgical Research
2008;146(2):211—7. p. 15.
[8] Cos¸kun D, Dag˘  Z, Göktas¸  P. Cerrahi alan infeksiyonu
gelis¸mesinde predispozan risk faktörlerinin aras¸tırılması.
Hastane I˙nfek Derg 1999;3:151—5.
[9] Gaynes RP, Culver DH, Horan TC, Edwards JR, Richards
C, Tolson JS. Surgcal site infection (SSI) rates in the
United States, 1992—1998: the National Nosocomial Infec-
tion Surveillance System basic SSI risk index. Clinical
Infectious Diseases 2001;33:69—77.10] Jodra VM, Diaz-Agero Perez C, Sainz de Los Terreros
Soler L, Saa Requejo CM, Dacosta Bellesteros D, Quality
Control Indicator Working Group. Results of the Span-
ish national nosocomial infection surveillance network
[
Available  online  at  www295
(VICONOS) for surgery patients from January 1997 through
December 2003. American Journal of Infection Control
2006;34:134—41.
11] Astagneau P, Rioux C, Golliot F, Brücker G, INCISO Net-
work Study Group. Morbidity and mortality associated
with surgical site infections: results from the 1997—1999
INCISO surveillance. Journal of Hospital Infection 2001;48:
267—74.
12] Fıs¸gın NT, Tanyel E, Topgül K, Sarıkaya H, Dog˘ancı L,
Tülek N. Kolon cerrahisi uygulanan hastalarda gelis¸en cer-
rahi alan infeksiyonları ve risk faktörleri. I˙nfeksiyon Dergisi
2008;22(3):141—5.
13] Brown SM, Eremin SR, Shlyapnikov SA, Petrova EA, Shirokova
LV, Goldmann D, et al. Prospective surveillance for surgical
site infection in St. Petersburg. Russian Federation. Infec-
tion Control and Hospital Epidemiology 2007;28:319—25.
14] Clarke SKR. Sepsis in surgical wounds with particular refer-
ence to Staphylococcus aureus.  British Journal of Surgery
1957;44:592—6.
15] Haley RW, Schaberg DR, Von Allmen SD, McGowan JE.
Estimating the extra charges and prolongation of hospi-
talization due to nosocomial infections: a comprasion of
methods. Journal of Infectious Disease 1980;141:248—57.
16] Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton
DJ. The impact of surgical-site infections in the 1990s:
attributable mortality, excess length of hospitalization, and
extra costs. Infection Control and Hospital Epidemiology
1999;20:725—30.
17] Hosoglu S, Sünbül M, Erol S, Altındis M, Caylan R, Demirdag
K, et al. national survey of surgical antibiotic prophy-
laxis in Turkey. Infection Control and Hospital Epidemiology
2003;24:758—61.
18] Roumbelaki M, Kritsotakis EI, Tsioutis C, Tzilepi P, Gikas
A. Surveillance of surgical site infections at tertiary care
hospital in Greece: incidence, risk factors, microbiol-
ogy and impact. American Journal of Infection Control
2008;36:732—8.
19] National Nosocomial Infections Surveillance (NNIS) report,
data summary from October 1986-April 1996, issued May
1996. A report from the National Nosocomial Infections
Surveillance (NNIS) System. American Journal of Infection
Control. 1996; 24: 380—88.
20] Mohammed IA. Prevalence of nosocomial wound infection
among postoperative patients and antibiotics patterns at
teaching hospital in Sudan. North American Journal of Med-
ical Science 2012;4(1):29—34.
21] C¸etin ES, Kaya S, Tas¸  T, Arıdog˘an BC, Demirci M. Cerrahi
alan infeksiyonlarında mikroorganizma proﬁli ve antibiyotik
duyarlılık durumu. ANKEM Derg 2006;20(2):89—93.
22] Levin AS. Multiresistant acinetobacter infections: a role
of sulbactam combinations in overcoming an emerging
worldwide problem. Clinical Microbiology and Infection
2002;8:144—53.
.sciencedirect.com
